Dental Hygiene: Page 293

Study: Cancer prognosis related to newly identified immune cells

By DrBicuspid.com staff writers

A newly discovered type of immune cells in tumors is associated with less severe cancer outcomes in humans and may have therapeutic potential, according to a new study in the journal Cancer Cell. The better outcomes were especially strong in head and neck cancers and in breast cancers, the researchers found.

October 23, 2014

Dental care linked to fewer respiratory infections in ICU patients

By DrBicuspid.com staff writers

Vulnerable patients in hospital intensive care units (ICUs) who received enhanced oral care from a dentist were at significantly less risk for developing a lower respiratory tract infection, such as ventilator-associated pneumonia, during their stay, according to a new study in Infection Control and Hospital Epidemiology.

October 22, 2014

Pitt researchers get $800K in grants to study HPV+ head/neck cancer

By DrBicuspid.com staff writers

University of Pittsburgh (Pitt) researchers have received $800,000 in grants to study gene mutations in patients whose head and neck cancer was caused by human papillomavirus (HPV) in hopes of finding a more effective, less toxic therapy for the disease.

October 22, 2014

Health experts call for action to tackle athletes' poor oral health

By DrBicuspid.com staff writers

Poor oral health affects elite athletes' general health and performance, and it must be remedied, according to a consensus statement published by University College London health experts and sporting bodies in the British Journal of Sports Medicine.

October 22, 2014

ADEA president urges action, education on fluoride benefits

By Richard Valachovic, DMD, MPH

In this column, American Dental Education Association (ADEA) President and CEO Dr. Richard Valachovic cites the scientific evidence behind the use of fluoride in community water and urges dental professionals in all communities to take the lead on this issue.

October 22, 2014

Study: Potential link between breast cancer genes, salivary gland cancer

By Donna Domino

Researchers have found a potential link between mutations in the BRCA1 and BRCA2 breast cancer genes and salivary gland cancer, according to a new study in JAMA Otolaryngology -- Head & Neck Surgery.

October 20, 2014

Review of guidelines can calm Ebola fears

By DrBicuspid.com staff writers

As dentists and other healthcare practitioners are being queried by their patients about the Ebola virus and their practice's infection-control procedures, a review of the ADA and Centers for Disease Control and Prevention guidelines is called for so you can provide accurate information for your staff and your patients.

October 15, 2014

Crosstex responds to infection-control inquiries due to Ebola, enterovirus

By DrBicuspid.com staff writers

Face mask manufacturer Crosstex has responded to numerous healthcare practitioners who have asked about appropriate personal protective equipment in the wake of prominent news coverage of Ebola and enterovirus.

October 13, 2014

ADA 2014: Friday highlights

By Tony Edwards

SAN ANTONIO - The American Dental Association (ADA) 2014 annual meeting continued on Friday, with a crowded exhibit floor, dozens of continuing education offerings, and the presentation of more 2014 Dental Excellence Awards. Here are a few highlights from Friday.

October 12, 2014

Biolase announces ADA courses, workshops at ADA 2014

By DrBicuspid.com staff writers

SAN ANTONIO - Biolase announced that it will share corporate updates and showcase its entire line of products, including its flagship WaterLase iPlus all-tissue laser, at the ADA 2014 annual meeting, held October 9-14.

October 8, 2014

Dental Excellence Awards 2014 winners

By Tony Edwards

DrBicuspid.com is pleased to announce the winners of the 2014 Dental Excellence Awards, recognizing the very best in people, products, and services that are helping to improve the dental industry. Awards are being handed out at this year's ADA 2014 annual meeting in San Antonio.

October 8, 2014

ACD gets $1.4M to develop test for detecting non-Hodgkin lymphomas

By DrBicuspid.com staff writers

Advanced Cell Diagnostics (ACD) has received a two-year $1.4 million grant from the National Cancer Institute (NCI) to develop and validate a diagnostic test for differentiating various B-cell non-Hodgkin lymphomas from benign lymphoproliferative diseases.

October 7, 2014

Previous Page

Page 293 of 586

Next Page